Journal article
Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry
Abstract
AIMS: Vitamin K antagonists (VKAs) need to be individually dosed. International guidelines recommend a target range of international normalised ratio (INR) of 2.0-3.0 for stroke prevention in atrial fibrillation (AF). We analysed the time in this therapeutic range (TTR) of VKA-treated patients with newly diagnosed AF in the ongoing, global, observational registry GARFIELD-AF. Taking TTR as a measure of the quality of patient management, we …
Authors
Haas S; Cate HT; Accetta G; Angchaisuksiri P; Bassand J-P; Camm AJ; Corbalan R; Darius H; Fitzmaurice DA; Goldhaber SZ
Journal
PLOS ONE, Vol. 11, No. 10,
Publisher
Public Library of Science (PLoS)
DOI
10.1371/journal.pone.0164076
ISSN
1932-6203